No CrossRef data available.
Article contents
Lipid supplementation in schizophrenia
Published online by Cambridge University Press: 03 January 2018
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0007125000153875/resource/name/firstPage-S0007125000153875a.jpg)
- Type
- Columns
- Information
- Copyright
- Copyright © 1999 The Royal College of Psychiatrists
References
Moser, H. W. (1993) Lorenzo oil therapy for adrenoleukodystrophy: a prematurely amplified hope. Annals of Neurology, 34, 121–122.Google ScholarPubMed
Moser, H. W., Moser, A. B., Smith, K. D., et al (1992) Adrenoleukodystrophy: phenotypic variability and implications for therapy. Journal of Inherited Metabolic Disorders, 15, 645–664.CrossRefGoogle ScholarPubMed
Poulos, A., Gibson, R., Sharp, P., et al (1994) Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Annals of Neurology, 36, 741–746.CrossRefGoogle ScholarPubMed
Walker, N. P., Fox, H. C. & Whalley, L. J. (1999) Lipids and schizophrenia. British Journal of Psychiatry
174, 101–104.Google ScholarPubMed
Zinkham, W. H., Kidder, T., Borel, M. S., et al (1993) Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy. New England Journal of Medicine, 328, 1126–1127.CrossRefGoogle ScholarPubMed
eLetters
No eLetters have been published for this article.